Molecular Diagnosis and Therapy

Author’s Reply to ‘‘Comment on ‘Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis’’

Publication type: Journal Article
Publication date: 2025-01-02
scimago Q1
wos Q1
SJR: 1.214
CiteScore: 7.8
Impact factor: 4.1
ISSN: 11771062, 11792000
Found 

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Qiao W. et al. Author’s Reply to ‘‘Comment on ‘Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis’’ // Molecular Diagnosis and Therapy. 2025.
GOST all authors (up to 50) Copy
Qiao W., Jia Z., Guo W., Liu Q., GUO X., Deng M. Author’s Reply to ‘‘Comment on ‘Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis’’ // Molecular Diagnosis and Therapy. 2025.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s40291-024-00765-3
UR - https://link.springer.com/10.1007/s40291-024-00765-3
TI - Author’s Reply to ‘‘Comment on ‘Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis’’
T2 - Molecular Diagnosis and Therapy
AU - Qiao, Weiqiang
AU - Jia, Zhiqiang
AU - Guo, Wanying
AU - Liu, Qipeng
AU - GUO, XIAO
AU - Deng, Miao
PY - 2025
DA - 2025/01/02
PB - Springer Nature
SN - 1177-1062
SN - 1179-2000
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Qiao,
author = {Weiqiang Qiao and Zhiqiang Jia and Wanying Guo and Qipeng Liu and XIAO GUO and Miao Deng},
title = {Author’s Reply to ‘‘Comment on ‘Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis’’},
journal = {Molecular Diagnosis and Therapy},
year = {2025},
publisher = {Springer Nature},
month = {jan},
url = {https://link.springer.com/10.1007/s40291-024-00765-3},
doi = {10.1007/s40291-024-00765-3}
}
Found error?